STOCK TITAN

Commodore Capital reports 5%+ stake in InflaRx (IFRX)

(Neutral)
(Neutral)
Form Type
SCHEDULE 13G

Rhea-AI Filing Summary

InflaRx N.V. shareholder Commodore Capital LP, together with Commodore Capital Master LP, Robert Egen Atkinson, and Michael Kramarz, reports beneficial ownership of 7,475,000 ordinary shares of InflaRx N.V. as of August 10, 2026. This represents 5.1% of the outstanding ordinary shares, based on 147,368,221 shares outstanding as of June 30, 2026.

The filers report no sole voting or dispositive power over InflaRx shares and shared voting and shared dispositive power over 7,475,000 shares. Commodore Capital LP acts as investment manager to Commodore Capital Master LP, while Atkinson and Kramarz are managing partners exercising investment discretion.

Positive

  • None.

Negative

  • None.
Shares beneficially owned 7,475,000 shares Ordinary shares beneficially owned by the filers as of August 10, 2026
Ownership percentage 5.1% Percentage of InflaRx N.V. ordinary shares beneficially owned by the filers
Shares outstanding 147,368,221 shares InflaRx N.V. ordinary shares outstanding as of June 30, 2026
Sole voting power 0 shares Shares over which each filer has sole power to vote
Shared voting power 7,475,000 shares Shares over which each filer has shared power to vote
Sole dispositive power 0 shares Shares over which each filer has sole power to dispose
Shared dispositive power 7,475,000 shares Shares over which each filer has shared power to dispose
beneficially own financial
"the Firm may be deemed to beneficially own an aggregate of 7,475,000 ordinary shares"
Beneficially own means having the economic rights and risks of a security—such as the right to receive dividends, sell the shares, or profit from price changes—whether or not your name appears on the official share register. Think of it like renting a car: you use it and reap the benefits even if the title lists someone else. Investors care because beneficial ownership determines who truly controls value, must be disclosed under securities rules, and can signal potential influence or trading activity that affects a stock’s price.
shared voting power financial
"6 | Shared Voting Power 7,475,000.00"
Shared voting power occurs when two or more parties jointly have the right to vote or decide how a block of company shares is cast, like co-owners who must agree before moving a piece of furniture. Investors care because who controls voting rights affects board elections, major corporate decisions and takeover outcomes, and shared control can alter regulatory disclosures and the practical influence any holder has over a company’s direction and value.
shared dispositive power financial
"8 | Shared Dispositive Power 7,475,000.00"
investment manager financial
"The Firm is the investment manager to Commodore Master."
Schedule 13G financial
"Ownership percentages are based on 147,368,221 shares ... in the Issuer's Rule 424(b)(4) Prospectus"
A Schedule 13G is a formal document that investors file with the government when they acquire a large ownership stake in a company, usually for investment purposes rather than control. It helps keep the public informed about who owns significant parts of a company's shares, which can influence how the company is managed and how investors make decisions. Filing this schedule is important for transparency and understanding the ownership landscape of publicly traded companies.

FAQ

What percentage of InflaRx N.V. (IFRX) does Commodore Capital report owning?

Commodore Capital and related filers report beneficial ownership of 5.1% of InflaRx N.V.. This stake corresponds to 7,475,000 ordinary shares, calculated against 147,368,221 shares outstanding as of June 30, 2026, according to the company’s referenced prospectus.

How many InflaRx N.V. (IFRX) shares does Commodore Capital beneficially own?

The filers beneficially own 7,475,000 ordinary shares of InflaRx N.V. This position is reported as of August 10, 2026 and represents shared voting and dispositive power over these shares, with no sole voting or dispositive authority reported.

What is the total number of InflaRx N.V. (IFRX) shares outstanding used for the 5.1% calculation?

The ownership percentage is based on 147,368,221 ordinary shares outstanding. This outstanding share count is stated as of June 30, 2026 and comes from InflaRx N.V.’s Rule 424(b)(4) prospectus referenced in the Schedule 13G filing.

Who are the filers on this Schedule 13G for InflaRx N.V. (IFRX)?

The Schedule 13G is filed by Commodore Capital LP, Commodore Capital Master LP, Robert Egen Atkinson, and Michael Kramarz. Commodore Capital LP acts as investment manager to Commodore Capital Master LP, and Atkinson and Kramarz are managing partners exercising investment discretion.

What voting power do the Commodore Capital filers report over InflaRx N.V. (IFRX) shares?

The filers report 0 shares with sole voting power and 7,475,000 shares with shared voting power. They likewise report 0 shares with sole dispositive power and 7,475,000 shares with shared dispositive power over InflaRx N.V. ordinary shares.

As of what date is the InflaRx N.V. (IFRX) ownership by Commodore Capital measured?

The reported ownership of 7,475,000 InflaRx ordinary shares is measured as of August 10, 2026. The percentage of class, 5.1%, uses the issuer’s outstanding share figure of 147,368,221 shares as of June 30, 2026.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates





N44821101

(CUSIP Number)
08/10/2026

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G



Commodore Capital LP
Signature:Michael Kramarz
Name/Title:Managing Partner
Date:08/17/2026
Commodore Capital Master LP
Signature:Michael Kramarz
Name/Title:Authorized Signatory
Date:08/17/2026
Robert Egen Atkinson
Signature:Robert Egen Atkinson
Name/Title:Authorized Signatory
Date:08/17/2026
Michael Kramarz
Signature:Michael Kramarz
Name/Title:Authorized Signatory
Date:08/17/2026
Exhibit Information

Exhibit 1: Joint Filing Agreement